Abstract An understanding of the time course and correlation with injury of heat shock proteins (HSPs) released during brain and/or spinal cord cellular stress (ischemia) is critical in understanding the role of the HSPs in cellular survival, and may provide a clinically useful biomarker of severe cellular stress. We have analyzed the levels of HSPs in the cerebrospinal fluid (CSF) from patients who are undergoing thoracic aneurysm repair. Blood and CSF samples were collected at regular intervals, and CSF was analyzed by enzyme-linked immunosorbent assay for HSP70 and HSP27. These results were correlated with intraoperative somatosensory-evoked potentials measurements and postoperative paralysis. We find that the levels of these proteins in many patients are elevated and that the degree of elevation correlates with the risk of permanent paralysis. We hypothesize that sequential measurement intraoperatively of the levels of the heat shock proteins HSP70 and HSP27 in the CSF can predict those patients who are at greatest risk for paralysis during thoracic aneurysm surgery and will allow us to develop means of preventing or attenuating this severe and often fatal complication. 
Abstract An understanding of the time course and correlation with injury of heat shock proteins (HSPs) released during brain and/or spinal cord cellular stress (ischemia) is critical in understanding the role of the HSPs in cellular survival, and may provide a clinically useful biomarker of severe cellular stress. We have analyzed the levels of HSPs in the cerebrospinal fluid (CSF) from patients who are undergoing thoracic aneurysm repair. Blood and CSF samples were collected at regular intervals, and CSF was analyzed by enzyme-linked immunosorbent assay for HSP70 and HSP27. These results were correlated with intraoperative somatosensory-evoked potentials measurements and postoperative paralysis. We find that the levels of these proteins in many patients are elevated and that the degree of elevation correlates with the risk of permanent paralysis. We hypothesize that sequential measurement intraoperatively of the levels of the heat shock proteins HSP70 and HSP27 in the CSF can predict those patients who are at greatest risk for paralysis during thoracic aneurysm surgery and will allow us to develop means of preventing or attenuating this severe and often fatal complication. (Cina et al. 2004; Safi and Miller 1999) . Any improvement in our ability to predict, detect, and intervene in the progression of ongoing spinal cord ischemia to prevent permanent damage would be a major advance and would be greatly aided by having a real-time, predictive marker for an elevated risk of paralysis. The heat shock proteins (HSPs) are members of a highly conserved family of molecular chaperones, some of which are rapidly induced by severe stress. The rapidly inducible form of HSP70 is normally near the lower limit of detection by enzyme-linked immunosorbent assay (ELISA; ∼1 ng/ml) in the CSF of healthy humans (unpublished results from Dr. Hecker's IRB-approved human CSF collection study) and remains so under normal conditions, including, for example, exercise to exhaustion (Dalsgaard et al. 2004 ). The inducible members of the HSP70 and HSP27 families are associated with cellular protection and recovery after a near lethal stress and have also been used as markers for tissues or organs that have been exposed to a near-lethal stress (Beere 2005; Da Rocha et al. 2005) ; it is this feature that we will exploit in this study. Release, transcription, and translation of the inducible HSPs are among the fastest of intracellular severe stress responses. We propose that the heat shock proteins HSP70 and HSP27 are biomarkers that can detect acute spinal cord ischemia during thoraco-abdominal aortic aneurysm (TAAA) resection.
Methods

Surgical procedures
This study received IRB approval, and written informed consent was obtained from all study patients. All patients admitted to our institution for TAAA repairs from 2003 through 2006 who had lumbar CSF drains placed as part of the standard care were eligible for the study. Patients with significant preoperative neurologic deficits or acute preoperative neurologic events were excluded. Demographic data were collected preoperatively. Formal NIH Stroke Scale (NIHSS) and lower extremity American Spinal Injury Association (ASIA) scales were performed by a certified neurologist, who was not blinded to procedure or outcome, at baseline and 12, 24, and 48 h postoperatively and at discharge. Cases in which acute neurologic changes were detected were subjected to further NIHSS and ASIA exams during a detailed neurologic examination, along with appropriate neuroimaging to confirm the existence of spinal or brain ischemia and exclude peripheral nerve or muscle injury. If an episode of spinal ischemia was detected intraor postoperatively, our institution's standard protocol was followed to attempt to reverse ongoing ischemia (Cheung et al. 2002; Cheung et al. 2005; McGarvey et al. 2007 ). Briefly, this protocol involves pharmacologic elevation of the mean arterial pressure (MAP), increasing intravenous fluids, replacing the lumbar drain if it had been removed, and CSF drainage to 8-12 mmHg. Clinical variables included age, race, gender, medical history, presentation status (emergent versus scheduled), whether deep hypothermic circulatory arrest (DHCA) was induced intraoperatively, whether intercostal vessels were re-implanted, presence of dissection or contained rupture, the repair type [cardiopulmonary bypass (CPB) with DHCA, left atrium/femoral artery bypass (LA/FA), thoracic endovascular aortic repair (TEVAR)], cross-clamp time, circulation arrest time, bypass time, maximal change in intraoperative MAP, and extent of repair. All patients received a narcotic-based anesthetic with inhaled isoflurane in oxygen. For open TAAA, circulation management consisted of either distal aortic partial left heart bypass with core cooling to 32°C (LA/FA bypass) or a deep hypothermic technique utilizing full cardiopulmonary bypass via the left chest with an open proximal anastomosis. Left atrium to femoral artery (LA/FA) bypass was used for aneurysms or dissections that did not involve the aortic root or aortic arch (type B or descending). If the arch vessels or aortic root were involved, either primarily or in a retrograde manner from the descending aorta, then deep hypothermic circulatory arrest (DHCA) with cardiopulmonary bypass was performed, with retrograde cerebral perfusion. For LA/ FA management bypass, flow rates averaged 2.5 l/min, adjusted to achieve a target distal aortic perfusion pressure of at least 60 mmHg, while maintaining proximal aortic pressure of at least 90 mmHg. Repairs involving the distal arch repair required utilization of DHCA, systemic cooling on CPB until the electroencephalogram (EEG) reached electrical cerebral silence (12-18°C), then termination of CPB to perform the open proximal anastomosis with total body retrograde cerebral perfusion (300-500 cm/min at a central venous pressure of 12-15 mmHg) via an unsnared superior vena cava. After completion, arterial circulation was reinitiated via the proximal descending Dacron graft, the distal anastomosis was performed, and the patient was rewarmed. For combined distal arch and type II and III TAAA repairs, arterial circulation was reinitiated with both proximal and distal femoral artery perfusion. Lumbar CSF drains were used in both LA/FA bypass and hypothermic cases. The spinal cord central pressure is maintained at 10-12 mmHg with lumbar CSF drainage, in theory to maximize the perfusion pressure gradient between systemic circulation and spinal cord. The lumbar CSF drain is usually clamped 24 h after surgery and removed after 48 h if there are neurologic deficits. Intercostal arteries were reimplanted in all patients when possible. Three patients in this cohort underwent descending thoracic aortic repair involving TEVAR without CPB involving general anesthesia, femoral artery cannulation, angiography, and aneurysm exclusion using an aortic stent graft.
CSF sample collection
Serial CSF samples were collected after informed consent as a part of our IRB-approved protocols at the following time points (when possible): (A) lumbar drain placement immediately after induction; (B) at the time of aortic crossclamp in cases involving LA/FA bypass, or time of restart of CPB after DHCA, or aortic stent deployment in TEVAR procedures; (C) 1 h after B, (D) 2 h after B, (E) 12 h after B, and (F) 24 h after B. Further samples were collected at various time points if signs of paraparesis developed postoperatively. Samples were not collected if the ICP was not greater than 8 mmHg or the lumbar drain was not functional. Samples were immediately centrifuged, and the supernatants free of cell debris were stored frozen at −80°C.
We measured HSP70 and HSP27 in CSF samples after surgery was finished, and the postoperative outcomes of these patients were known. Patient results were divided into two subsets of patients: (1) patients with paraplegia ('permanent', or resolved with intervention, 'transient') and (2) patients with no signs or symptoms of paraplegia postoperatively ('normals'). Patients with intraoperative somato sensoryevoked potentials (SSEP) changes (with or without paraplegia) were noted and HSP results correlated with outcomes.
ELISA assay for HSP70 and HSP27 HSP70 and HSP27 were quantitatively measured with StressXpress HSP70 and HSP27 ELISA kits (EKS-700 and EKS-500, respectively Stressgen, Vancouver, BC, Canada). These kits use a mouse monoclonal antibody on pre-coated 96-well immunoassay plates. HSP70 and HSP27 were captured by immobilized antibodies by loading 100 μl CSF/well in duplicate on the plates, followed by incubation at 4°C overnight. After rinsing, captured HSP70 and HSP27 were probed by incubation at room temperature (RT) with secondary biotinylated rabbit polyclonal anti-mouse antibody (1:500 dilution). Unbound secondary antibodies were removed by rinsing. Biotinylated antibodies were incubated at RT with an avidin-horseradish peroxidase conjugate diluted 1:500. After rinsing, the assay was developed by incubation with tetramethylbenzidine substrate and intensity was measured in a microplate reader (Dynex Technology) at 450 nm. Standard curves were plotted on a log-log scale versus absorbance. Sequential sample results for HSP27 and HSP70 were tabulated and analyzed.
Statistical methods
All statistical analyses used the commercially available statistical packages (Statistical Applications Software Version 9.1, SAS Institute, Cary, NC, USA) and R (The R Project for Statistical Computing Version 2.6.0). The primary exposure variables were measurements of the human CSF proteins HSP27 and HSP70 taken at up to ten time points per patient during the surgical procedure or postoperatively. We also considered patient demographic characteristics and pre-and intrasurgical factors. Our primary outcome was the binary indicator of paralysis. To characterize the within-patient HSP27 and HSP70 values, we calculated the following summary statistics to serve as our primary exposure variables: We characterized differences between binary paralysis outcome groups with respect to several demographic and surgical variables in addition to the HSP70 and HSP27 variables listed above. For discrete variables, we calculated the number of observations in each level/outcome group combination and tested for significant differences between groups with Fisher's exact tests. For continuous variables, we calculated medians and inter-quartile ranges and used the nonparametric Wilcoxon rank sum test to assess significant differences between outcome groups. All p values represent two-sided hypothesis tests.
We plotted mean and cumulative values of HSP27 and HSP70 at each time point to evaluate the relationship between changes in HSP measured in the CSF and postoperative paraplegia. We used boxplots to depict the relationship between the binary paralysis outcome and patient demographic variables and our calculated withinpatient HSP70 and HSP27 values.
Multivariable logistic regression
We used a series of stepwise multivariable logistic regression to evaluate the effects of our primary exposure variables on the paralysis outcome. Each of the primary exposure HSP27 and HSP70 variables was considered in a separate model. We included demographic and surgical variables as potential confounders in each model; stepwise regression methods were employed to determine the best final model. The criterion for the stepwise selection of variables was p<0.25. The C-Statistic was used to evaluate the goodness of fit of the models (C=0.80).
Results
Forty-eight patients consented to participate in this study during the time period reported in this paper. Of the 48, surgery was canceled for one patient due to the presence of blood in the CSF at the time of lumber drain placement. In 11 patients, a lumbar drain could not be placed for technical reasons, no CSF was collected, or surgery was cancelled for other reasons. We evaluated HSP70 and HSP27 in CSF samples after surgery was finished, and the postoperative outcomes of these patients were known. Patient results were divided into two mutually exclusive subsets of patients: (1) patients with paraplegia ('permanent', or resolved with intervention, 'transient') and (2) patients without signs or symptoms of paraplegia postoperatively ('normals'). Table 1 lists demographic, preoperative, and surgical statistics for the study population. Patients ranged in age from 40 to 80, with 20 men and 17 women. None of the demographic variables of age, race, and sex was significantly associated with the paralysis outcome. However, patient smoking history has a statistically significant effect on the paralysis outcome for our group of patients. Patients who developed postoperative paraplegia reported a median of 60 (inter-quartile range, 50 to 75) pack years, compared with only 7 (inter-quartile range, 0 to 45) pack years among patients who did not develop paraplegia (p=0.0011). There were significantly more patients with chronic renal insufficiency (CRI) in the paralysis outcome group (40%, standard error=26%) than in the normal outcome group (4.6%, standard error=4.7%). Significantly fewer patients in the postoperative paralysis outcome group than in the normal outcome group underwent surgeries other than DHCA or LA/FA [0% versus 22.7% (standard error=8.9%)]. This 'other' category includes three TEVAR (stent) patients and two patients who were repaired with open surgical procedures that did not require either DHCA or cardiac bypass.
Of the 37 non-consecutive thoraco-abdominal aneurysm patients we studied, 13 had large increases in HSP70 and HSP27 within 2 h of cross-clamping the aorta, and 12 more had large increases within 48 h of cross-clamp. Of these 25, 13 had postoperative paraparesis of some degree. Twentytwo of the 25 patients who had significant HSP increases had either intraoperative SSEP or EEG changes consistent with brain or spinal cord ischemia, or neurological evidence of paraplegia or stroke postoperatively. Of the 12 patients who did not have significant HSP increases, only one had any evidence of paraplegia or central ischemia by intraoperative SSEP. Overall, an overwhelming majority of patients with either paraparesis and/or SSEP changes consistent with central ischemia had large increases in HSP70 and HSP27 at multiple time points in the perioperative period.
We plotted cumulative and average mean values of HSP70 and HSP27 at each time point after induction of anesthesia. The cumulative averages of HSP70 (shown in Fig. 1 ) and HSP27 levels from those patients who went on to develop paraplegia were larger than those of the patients who did not develop paraplegia. Mean values for HSP70 were also higher at each intra-or postoperative time point C through F for paraplegics versus normals, respectively (shown in Fig. 2 ). However, only HSP70 values at time points E and F were statistically significant in both Figs. 1 and 2 in these sample sizes. Graphs for HSP27 were similar (not shown).
We also plotted mean HSP70 and HSP27 levels to compare surgical technique (LAFA and DHCA) with changes in the heat shock proteins (HSP70 shown in Fig. 3 , with similar results seen for HSP27). The percentage of patients who developed paraplegia was comparable in both open surgical repair subgroups (four out of ten DHCA patients, and ten out of 20 LAFA patients). However, the mean HSP70 levels at successive time points in patients with paraplegia after DHCA are considerably higher than for patients with paraplegia after LAFA, especially 12 and 24 h post cross-clamp (Fig. 3) .
Figures 4 and 5 contain graphical and numerical comparisons of the paralysis and non-paralysis outcome groups with respect to each of the calculated variables listed above in Table 2 . Figures 4 and 5 display side-by-side boxand-whisker plots of the independent variable distributions within the paralysis and non-paralysis groups for Hsp70 and Hsp27, respectively. In each box, the first quartile (Q1), median, and third quartile (Q3) are represented by the bottom of the box, thick line inside the box, and top of the box, respectively. "Whiskers" extend to the nearest data point within 1.5 times the inter-quartile range of the distribution. Individual points beyond the whiskers depict outliers. The p value resulting from a Kruskal-Wallis test of equal location parameters (i.e., medians) is given in Table 2 . Small p values (<0.05) indicate statistically significant differences between the two outcome groups. Finally, we explored the possibility that these effects are confounded with basic patient demographic effects such as age, race, gender, and smoking history.
Patient smoking history has a statistically significant effect on the paralysis outcome for our group of patients. Patients with a longer smoking history are more likely to experience paralysis. As expected, increasing age and emergency status increase the risk for paraplegia, while race and gender did not impact outcome. The numerical summaries for the results depicted graphically in Figs. 4 and 5 are given in Table 2 . Table 3 , which lists effects with p values <0.10, summarizes the detailed logistic regression results. The results are further evidence that, for our study group of 37 patients, HSP70 and HSP27 values observed during surgery are indicative of paralysis. All significant effects are positive, which means that patients with higher values of the calculated quantities we considered were more likely to experience paralysis. More specifically, we conclude that patients with HSP70 and HSP27 measurements in CSF that were non-linear over time (i.e., higher RSE values), experienced more extremes (higher maximums and ranges), or had larger positive average changes from the pre-to post-cross-clamp time periods were more likely to experience paralysis than other patients. It is also interesting to note that patients with longer smoking histories were more likely to experience paralysis than others.
Patients with non-linear HSP27 and HSP70 changes over time, as seen in larger within-patient linear regression Table 2 for detailed results, including p values).
Stepwise multivariable logistic regression results provide further evidence that, for our study group of 37 patients, within-patient patterns of pre-and intraoperative HSP27 and HSP70 measurements in the CSF are indicative of paralysis, even when we controlled for demographic and surgical variables (Table 3 ). More specifically, we verify first that, even after adjustment, patients with HSP measurements that were non-linear over time (i.e., higher RSE values) were more likely to experience postoperative paraplegia (HSP70 odds ratio=5.574, 95% confidence interval 1.538 to 20.193, p=0.0089). We also observe that patients with relatively extreme pre-and intraoperative HSP values were more likely to experience paralysis [maximum HSP70 odds ratio=1.870 (95% CI: 1.202 to 2.910), p=0.0055; within-patient HSP70 range odds ratio=1.907 (95% CI, 1.204 to 3.019), p= 0.0059]. Finally, we conclude that, even after adjusting for demographic, preoperative, and intraoperative variables, larger positive average HSP27 changes from the pre-to post-cross-clamp time periods were indicative of paralysis [time point B to C percent change odds ratio=1.028 (95% CI, 0.999 to 1.057), p=0.0617; average AB to C + change odds ratio=3.815 (95% CI, 1.064 to13.67), p=0.0399]. Fig. 1 Average cumulative HSP70 measurements by paralysis outcome with 95% confidence bars
Discussion
As a corollary to our ongoing efforts to deliver transient neuroprotective genes to the central nervous system (CNS), we measured HSP27 and HSP70 expression as presumptive biomarkers for ischemic spinal cord injury in the CSF of patients who were undergoing TAA or TAAA repair. Previous work done by us and by others led us to hypothesize that HSP70 (Mariucci et al. 2007; Nowak and Jacewicz 1994; Westerheide and Morimoto 2006) and 27 levels (Latchman 2005; Patel et al. 2005; Wagstaff et al. 1999) would be found at significant levels in the CSF in the presence of CNS ischemia intraoperatively, and that the quantitative HSP70/27 level would be predictive of the severity of ongoing ischemia and the potential for paralysis. Knowledge of elevated HSP70 and HSP27 levels in the CSF would allow the anesthesiologist, neurologist, and surgeon the opportunity to alter surgical procedures or, if elevated preoperatively, to cancel or modify a surgical resection. We have confirmed this hypothesis.
The highly conserved heat shock proteins have multiple roles in vivo. HSP70 mediates cell protection and homeostasis, and recent evidence suggests that HSP70 is important in the regulation of apoptosis and inflammatory responses as well (Beere 2004) . Numerous studies have used HSP70 immunohistochemistry as a marker for injury, for example, after cardiac surgery (Becker et al. 2007; Dybahl et al. 2004) or in the CNS (Chen et al. 1998; Lindsberg et al. 1996; Mariucci et al. 2007; Nowak and Jacewicz 1994) . Transcription and translation of these proteins increases dramatically in response to hypoxia or ischemia (Li et al. 2004; Nowak and Jacewicz 1994) . This serves as an endogenous mediator of intracellular protection, not just in the CNS but in all tissues. Regner et al. (Da Rocha et al. 2005) showed that elevated serum HSP 70 levels, for example, predicted a poor outcome after severe traumatic brain injury in patients. Hart et al. Cizkova et al. 2004 ) showed a robust induction of HSPs with 6 and 12 min of spinal cord ischemia in a microarray analysis. Contreras (Contreras et al. 2005) demonstrated spinal cord protection using immediate ischemic pre-conditioning guided by SSEP measurements but did not measure HSPs as a part of this study. Robinson et al. (2005) showed an increase in HSP70 in response to ischemia in motoneurons, which reduced damage. They also showed that in vitro application of exogenous HSP70 to neuronal cells with conferred protection and improved long term motor neuron survival. We are most interested in Fig. 2 Average HSP70 measurements by paralysis outcome with 95% confidence bars Fig. 3 Average HSP70 measurements by type of surgery with 95% confidence bars B Fig. 4 Within-patient HSP70 summaries by paralysis outcome the CNS, where multiple groups have also shown that the inducible heat shock proteins, in particular the 70-kDA HSP70, confer neuroprotection in the brain from injury (Kelly and Yenari 2002; Lee et al. 2006; Rajdev et al. 2000; Tsuchiya et al. 2003; van der Weerd et al. 2005) . These multiple roles for HSP70 and HSP27 led us to investigate in this study whether quantitative measurements of HSP70 and HSP27 can be used to predict ischemic injury.
We assume that CSF HSP levels reflect spinal cord ischemia due to the type and location of surgery. However, as HSPs are induced in any tissue that is exposed to a nearlethal stress, CSF HSPs could also be due to brain ischemia or even due to increased systemically circulating levels if the blood brain barrier is not intact. For example, in only one patient was the initial HSP70 level significantly greater than 2.0 at the first time point. This patient had had a carotid endarterectomy (CEA) the previous day, with a normal post-CEA neurological exam. By measuring HSP70 and HSP27 in the CSF at multiple time points, we have assured ourselves that a significant increase in HSP is not an isolated time point. Rapid measurement of these HSP levels would allow spinal cord preservation techniques to be utilized, some of which are done routinely already, others not. These include draining CSF to maximize perfusion gradient, increasing MAP, cooling the epidural space, reimplantation of additional intercostal arteries, and advising the surgeons to consider alternative operative procedures. Our data support the hypothesis that there is a significant expression of HSP70 and HSP27 when the spinal cord is exposed to ischemia. HSP values appeared to be more sensitive than SSEP (data not shown here) for predicting postoperative paraplegia, as a greater percentage of patients with increases in HSPs and persistently elevated levels of HSPs end up paraplegic than those with SSEP changes. The combination of SSEP changes and HSP70 levels might be even more useful in combination. In the postoperative period, patients are not monitored by SSEP, but HSP levels can be measured until removal of the lumbar drain. We were somewhat limited by the number of samples that were available for analysis. More frequent sample collection during the first 6 to 12 h after cross-clamp might allow a critical threshold for 'impending, irreversible spinal cord ischemia' to be determined. Some combination of the magnitude of HSP elevation (RSE<slope, range) and duration of increased HSP might well be highly predictive of impending irreversible ischemia.
We have noticed several other intriguing observations that will require additional patients to fully resolve. Although there are three surgical approaches, thoracic endovascular aortic repair (TEVAR), LA/FA partial bypass, and DHCA with full cardiopulmonary bypass (CBP), only LAFA and DHCA are open procedures. The percentage of patients who developed paraplegia was comparable in both groups of open repairs (four out of ten DHCA patients, and ten out of 20 LAFA patients). However, the mean HSP70 levels at successive time points in patients with plegia after DHCA are considerably higher than for patients with plegia after LAFA, especially 12 and 24 h post-cross-clamp. This trend (which was not statistically significant) was seen both in patients with paraplegia and in patients who had no postoperative neurological complications. It is unclear whether DHCA has a greater degree of ischemic injury than LAFA, whether this is brain or spinal cord injury, and whether these patients are thus afforded protection from even greater injury by the induction of hypothermia. It is possible that these patients are suffering a sub-clinical neurocognitive injury that has been associated with full cardiopulmonary bypass. LA/FA patients who do not undergo bypass and are kept warmer (typically 32°C during bypass) during the operation, not only had paralysis at lower mean HSP 70 levels but also appeared to be at greater risk of permanent neurological injury. Two out of the four patients with neurological compromise after DHCA recovered fully, whereas only two of the ten patients in the LAFA group with similar complications recovered even partial function with intervention. The HSP70 level elevation noted in DHCA patients may represent a significantly higher level of ischemia that results from this operative approach due to a reliance on retrograde blood flow plus cardiopulmonary bypass to provide cerebral perfusion, or the elevation in HSP 70 may reflect increased expression of HSP70 systemically in DHCA, as hypothermia and hyperthermia are both known to induce HSP70. DHCA patients may reflect more extensive or complicated repairs and may be exposed to a double or triple insult: Severe hypothermia, complete cessation of CNS blood flow, and simultaneous cardiovascular bypass [although the interaction of cold, reperfusion, and coronary artery bypass graft (CABG) are poorly understood at bests. Further studies will be necessary to determine the neuroprotective effects of DHCA and the potentially lower risks associated with TEVAR.
The analysis results we have presented in this study clearly demonstrate a relationship between within-patient HSP27 and HSP70 values and paralysis. We do note that this study is observational in nature and that more data must be collected to make general conclusions. In general, we see that patients with non-linear, highly variable HSP values are more likely to experience paralysis as an outcome. This can provide the physician with an early warning for intervention. The next phase of analysis will focus on finding an actionable threshold for HSP values so that interventions during surgery can take place. We are continuing to collect data on additional patients both to validate these initial results and to further explore relationships between measurements taken during surgery and the risk (predictability) of paralysis.
